Clemondo Group AB (publ)
F:N170
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clemondo Group AB (publ)
F:N170
|
SE |
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
Electricite de France SA
PAR:EDF
|
FR |
|
P
|
PharmaSGP Holding SE
XMUN:PSG
|
DE |
|
M
|
Minor International PCL
SET:MINT
|
TH |
|
R
|
Rio Tinto PLC
XMUN:RIO1
|
UK |
|
JD.Com Inc
F:013A
|
CN |
|
Bio-Techne Corp
NASDAQ:TECH
|
US |
|
M
|
MGIC Investment Corp
F:MGC
|
US |
|
Francotyp Postalia Holding AG
F:FPH
|
DE |
|
S
|
Sunstone Hotel Investors Inc
F:UF2
|
US |
|
MTN Group Ltd
F:LL6
|
ZA |
|
Schindler Holding AG
F:SHRQ
|
CH |
Wall St Price Targets
N170 Price Targets Summary
Clemondo Group AB (publ)
According to Wall Street analysts, the average 1-year price target for N170 is 1.1 EUR with a low forecast of 1.09 EUR and a high forecast of 1.13 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is N170's stock price target?
Price Target
1.1
EUR
According to Wall Street analysts, the average 1-year price target for N170 is 1.1 EUR with a low forecast of 1.09 EUR and a high forecast of 1.13 EUR.
What is the Revenue forecast for Clemondo Group AB (publ)?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Clemondo Group AB (publ)?
Projected CAGR
35%
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 35%.
What is the Net Income forecast for Clemondo Group AB (publ)?
Projected CAGR
37%
Over the last 14 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 3 years is 37%.
